The fat you can pinch at your waist is not the fat this page is about. Visceral fat sits deeper, behind the abdominal muscles and around the organs, and it is a hormonally active part of body fat whose large amounts travel with metabolic and cardiovascular disease. That is why a waistline says more than a weight: the tape shows where fat is stored, the scale only how much you carry.

Key takeaways

1. What is visceral fat? Fat inside the abdomen, around the organs; in 3,001 Framingham adults scanned by CT it was more closely linked to metabolic risk than fat under the skin.

2. At home, the tape gives the most useful estimate: for adults with a BMI under 35, a waist under half your height is healthy.

3. A scale's visceral number is the maker's own index; one abdominal device, tested in 120 adults, tracked total belly fat more than visceral fat. A 7 is healthy or normal on Tanita and Omron.

4. Exercise lowered visceral fat in trials of adults with overweight or obesity even when weight barely changed, with the largest estimates for vigorous cardio and HIIT; every weight-loss method took more visceral than subcutaneous fat in percent, and none targeted it.

What is visceral fat?

Visceral fat is the fat stored inside the abdominal cavity, wrapped around the organs, split into fat inside and behind the cavity's lining (intraperitoneal and retroperitoneal); subcutaneous fat lies under the skin and is the only kind you can pinch. The inner store is the smaller of the two: in an MRI study of 39 men, it made up about 11 plus 7 percent of total body fat.

Small does not mean quiet: a large amount of visceral fat, called visceral obesity, goes with metabolic syndrome, cardiovascular disease and several cancers, colorectal cancer among them. These are associations, not proof that the fat causes the disease.

Measured across the whole abdomen by MRI, visceral volume averaged 2.7 liters in 121 healthy men (mean age 41.9) and 1.7 liters in 198 healthy women (mean age 48.1), with a spread so wide that neither mean works as a norm.

This is also why the popular rule of subtracting 10 from your body fat percentage to get a visceral level has no basis: the share is not fixed but differs with sex, age and fatness, and that MRI figure comes from 39 men in 1995.

Why visceral fat carries more risk than the fat you can pinch

Visceral fat is tied more closely to metabolic risk than subcutaneous fat. In 3,001 Framingham participants without cardiovascular disease, mean age 50, scanned by CT, only visceral fat added explanatory power for risk factors once BMI and waist were accounted for, and a position statement of two international expert bodies treats CT- or MRI-measured visceral fat as an independent marker of cardiometabolic risk: a marker, not a proven cause.

Each standard deviation of extra visceral fat went with 4.7-fold odds of metabolic syndrome in women, against 3.0-fold for the same step in subcutaneous fat, and in men the pair was 4.2 against 2.5; with one scan per person, that is an association, not a sequence.

If location carries the risk, removing a large volume of subcutaneous fat should leave metabolism largely untouched. A small study tested this in 15 women with abdominal obesity whose liposuction removed about 9 to 10.5 kilograms (20 to 23 lb) of subcutaneous belly fat: 10 to 12 weeks later, insulin sensitivity, inflammation markers, blood pressure, glucose and lipids had not changed significantly. The study was small and short, and a non-significant change is not proof that nothing changed.

A normal weight does not rule out a risky distribution. In NHANES III, which followed 15,184 US adults, a normal BMI combined with fat carried centrally at the waist, judged by waist-to-hip ratio, went with higher mortality: for a man with a BMI of 22, central obesity meant a hazard ratio of 1.87 compared with the same BMI without it, and for women of normal weight the figure was 1.48. A meta-analysis of 72 cohorts with about 2.5 million people agrees, with each extra 10 cm of waist linked to an 11 percent higher risk of death (pooled from 50 of the studies) and each 0.1 rise in waist-to-height ratio to 24 percent (pooled from 11), even after accounting for BMI.

How to measure visceral fat at home

At home you cannot see visceral fat, only estimate it, and the most practical tool is a tape measure. Find your lowest rib and the top of your hip bone, wrap the tape midway between them, just above the belly button, and read it after breathing out normally. Dividing that waist by your height gives the waist-to-height ratio, and for adults with a BMI under 35 the UK guideline NICE rates 0.4 to 0.49 as healthy.

Your waist against your height
Waist-to-height ratio bands for adults with a BMI under 35 (NICE) and the waist thresholds in use
MeasureWhat it meansSource
Waist-to-height ratio 0.4 to 0.49healthy central adiposity, no increased riskNICE NG246
Waist-to-height ratio 0.5 to 0.59increased central adiposity, increased riskNICE NG246
Waist-to-height ratio 0.6 or morehigh central adiposity, further increased riskNICE NG246
Waist 88 cm (35 in) women, 102 cm (40 in) menabdominal obesity threshold first used by the US NIHRoss 2020 (IAS/ICCR)
Waist about 80 cm women, 95 cm menrisk of death rose above these values in more than 680,000 European adultsRoss 2020 (IAS/ICCR)
Example: 85 cm waist / 170 cm height = 0.50
Measure midway between the lowest rib and the top of the hip bone, after breathing out. Bands are risk categories, not a visceral fat measurement. The waist thresholds were set for adults of European descent; some Asian populations use lower ones.

Hence the rule of thumb: keep your waist under half your height, which at 170 cm (67 in) means under 85 cm (33.5 in), where the NICE “increased” band begins. The waist-to-height ratio calculator does the division.

How do you know if your fat is visceral? Neither a pinch nor a mirror can tell; only a CT or MRI slice shows it directly. The tape takes in fat under the skin and inside alike, yet in 18,622 UK Biobank participants scanned by MRI, waist agreed moderately well with visceral fat, and the authors concluded it may be the most appropriate stand-in given cost and access. All were White, and a single reading can still be off.

Dividing by height adds something: in a meta-analysis of 31 papers with more than 300,000 adults, the ratio picked out diabetes, hypertension and cardiovascular risk better than waist circumference or BMI, in both sexes, though it flags risk factors rather than measuring fat. An international consensus calls waist circumference a vital sign and accepts the upper edge of the pelvis or the midpoint between lowest rib and pelvis as the site.

Visceral fat level on a scale: is 7 high?

A scale's visceral fat level is not a measurement but an index each maker estimates in its own way. On Tanita the rating runs from 1 to 59 and 1 to 12 counts as healthy, while Omron's runs from 1 to 30 with 1 to 9 as normal. A visceral fat rating of 7 is therefore not high: it sits inside the healthy band on Tanita's scale and the normal band on Omron's.

What your scale's number means
Visceral fat rating bands as defined by two scale makers (not a medical standard)
Bars: each maker’s full rating range on its own scale. Green: the healthy or normal band.
Tanita, rating 1 to 59107healthy 1 to 12too high 13 to 59Omron, rating 1 to 307normal 1 to 9high 10 to 14very high 15 to 30
Tanita, rating 1 to 59107healthy 1 to 12too high 13 to 59Omron, rating 1 to 307normal 1 to 9high 10 to 14very high 15 to 30
10 (Tanita): ≈ 100 cm², Japan's scan criterion for visceral fat obesity. 7: inside both makers' healthy or normal band.
Tanita: 1 point ≈ 10 cm² of visceral fat on MRI (maker's statement). Omron gives no cm² conversion. In an MRI test of one Tanita belly device, its reading followed total belly fat more than visceral fat.
Visceral fat rating bands as defined by two scale makers (not a medical standard)
MakerRatingBand
Tanita1 to 12healthy
Tanita13 to 59too high
Omron1 to 9normal
Omron10 to 14high
Omron15 to 30very high

The conversion is Tanita's own: one rating point corresponds to about 10 cm² of visceral fat on an MRI slice, so a 7 stands for roughly 70 cm² and a 10 for roughly 100 cm², the area at which Japan's obesity guideline defines visceral fat obesity, a cut-off set for Japanese adults. Omron's FAQ gives no conversion and escalates sooner, calling 10 to 14 high and 15 to 30 very high, whereas Tanita labels everything from 13 to 59 too high, so a 10 is healthy on one and high on the other.

The closest test we found used not a bathroom scale but a Tanita abdominal impedance device and compared it with MRI scans of 120 adults. The device's visceral reading followed all the fat in the belly closely but visceral fat itself far more loosely, and the authors judged that neither the device nor the tape was a useful proxy for visceral fat. That model dates from 2010, foot-to-foot scales work differently, and the larger Biobank analysis favored the tape.

How close each method comes to a scan
How closely each method matched MRI or CT visceral fat in validation studies
MethodWhat it measuresAgreement with a scan
MRI or CT scanvisceral fat area or volume directly (the reference)reference
DXA scanvisceral fat estimated from an X-ray body scanwith CT: r² 0.957; with MRI: ICC 0.73 to 0.94 (DXA visceral, trunk and belly fat)124 adults aged 18 to 90 (CT); 18,622 White UK Biobank adults (MRI)
Tape measure (waist)all fat and organs at the waist, under the skin and insidewith MRI visceral fat: ICC 0.73 to 0.7718,622 White UK Biobank adults
Abdominal impedance device (Tanita AB-140)a 'visceral fat level' from electrical resistancewith MRI visceral fat: r 0.65 (men) and 0.64 (women); with total belly fat: r 0.94 and 0.92120 adults
r and r² describe how closely two measurements move together; ICC how closely they agree. Different studies, different people: compare within a row, not across.

Where can you have visceral fat measured? CT and MRI measure it directly, and DXA, an X-ray body scan, comes close: in 124 adults aged 18 to 90, DXA estimates matched CT closely, reading 56 cm³ high on average, but the 95 percent limits of agreement for a single scan ran from 355 cm³ under to 468 cm³ over, and the validation covered one manufacturer's method.

What causes visceral fat to build up?

Visceral fat collects with time: with age, fat shifts toward the abdomen and into visceral fat while the lower body's subcutaneous fat shrinks, and this can happen with no change in weight, total fat or waist size. How much collects also differs with menopause, genes and ancestry.

Part of it is inherited. In Framingham, the heritability of visceral fat was estimated at 36 percent, against 57 percent for subcutaneous fat, a population estimate, not a personal fate. Ancestry matters as well: among 207 South Asian and 201 European adults in Canada, the South Asian participants carried more visceral fat at the same BMI, and in this cross-sectional analysis that extra fat accounted for 16 to 52 percent of the gap in cardiovascular risk factors.

In women the shift has a visible moment. The SWAN study followed 380 women, mean age 45.7 at the start, for a median of 11.8 years with DXA scans, and visceral fat began rising at the menopause transition by 6.24 percent a year, slowing to 1.47 percent a year after menopause. Waist and hip registered the shift less clearly, so a tape can lag behind during these years; the rates apply to the White participants, and the timing does not prove that hormones are the cause. More in our guide to weight gain in menopause.

How to lose visceral fat: why exercise works before the scale moves

Exercise lowered visceral fat in trials even when weight barely moved. In a meta-analysis of 117 studies with 4,815 people, regressions across 86 aerobic exercise arms and 87 diet arms estimated a 6.1 percent drop at zero weight loss with exercise against 1.1 percent with diet; these are model estimates, not trial results, and overall the larger visceral drop with exercise was only a trend (p = 0.08). The sign you can check at home is a smaller waist.

When the scale does not move
Estimated change in visceral fat at zero weight loss, exercise vs diet (model estimates from a meta-analysis of 117 studies; overall exercise vs diet difference a non-significant trend)
Bars: estimated change in visceral fat in percent, from zero. Further left: a larger drop.
Exercise (86 aerobic exercise arms)−6.1 %Diet (87 diet arms)−1.1 %
Exercise (86 aerobic exercise arms)−6.1 %Diet (87 diet arms)−1.1 %
Model estimates (where each regression line crosses zero weight loss), not results of single trials. Exercise vs diet on the overall drop in visceral fat across the meta-analysis: p = 0.08, a trend, not significant.
Estimated change in visceral fat at zero weight loss, exercise vs diet (model estimates from a meta-analysis of 117 studies; overall exercise vs diet difference a non-significant trend)
ArmEstimated change at zero weight loss, %
Exercise (86 aerobic exercise arms)−6.1 %
Diet (87 diet arms)−1.1 %

The scale hardly reacts because visceral fat is a small store, so even a clear drop there barely moves total weight. More on why the scale can stall while you train.

What are the signs you are losing visceral fat? One you can check comes from a 2023 meta-analysis of 40 randomized trials in 2,190 adults with overweight or obesity: exercise took 3.15 cm more off the waist than the control groups saw. Visceral fat itself fell by a small standardized effect size of 0.28 (pooled from 26 studies), and the effect grew by 0.15 for every 1,000 kcal of weekly exercise deficit.

An older meta-analysis of exercise without dieting (15 studies, 852 people with overweight) found a moderate effect size of 0.497 on visceral fat, which 5 controlled studies with 569 people translate into over 30 cm² in women and over 40 cm² in men, with moderate or vigorous aerobic training effective even after 12 weeks. Over 18 months, the CENTRAL trial put 278 sedentary adults with abdominal obesity or abnormal blood lipids (mean age 48, 89 percent men) on one of two diets: visceral fat fell by 22 percent across all groups, and moderate activity added to either diet took off another 6.67 cm², independent of weight loss.

Which exercise lowered it most? Whether the kind of training matters was tested by setting five types against no exercise in a 2026 network meta-analysis of 78 reports with 4,930 adults with overweight or obesity (mean age 43.1, 58.4 percent women). The largest estimates came from vigorous aerobic exercise and HIIT, HIIT meaning short hard intervals with recovery, each a moderate standardized effect size of 0.73, followed by combined training at 0.61, moderate to vigorous aerobic exercise at 0.53 and resistance training at 0.50. The uncertainty ranges overlap, which is why the order is not firm.

Which training lowered it
Effect of five exercise types on visceral fat against no exercise, standardized (network meta-analysis, 78 reports, 4,930 adults with overweight or obesity)
Bars: standardized effect against no exercise, from zero; further left: less visceral fat. Thin lines: the 95 % interval.
Vigorous aerobic−0.73HIIT−0.73Combined aerobic and strength−0.61Moderate to vigorous aerobic−0.53Resistance training−0.50
Vigorous aerobic−0.73HIIT−0.73Combined aerobic and strength−0.61Moderate to vigorous aerobic−0.53Resistance training−0.50
About 0.5 is a moderate effect, 0.8 a large one (Cohen). Intervals overlap: the ranking is not firm.
Effect of five exercise types on visceral fat against no exercise, standardized (network meta-analysis, 78 reports, 4,930 adults with overweight or obesity)
Exercise typeEffect (SMD)95 % interval
Vigorous aerobic−0.73−0.96 to −0.51
HIIT−0.73−0.94 to −0.53
Combined aerobic and strength−0.61−0.81 to −0.41
Moderate to vigorous aerobic−0.53−0.67 to −0.39
Resistance training−0.50−0.72 to −0.28

A 2012 meta-analysis of 35 trials had found no significant effect for resistance training alone (0.09, p = 0.49); the 2026 analyses found a real one, with a smaller estimate than vigorous aerobic training. The second, with 60 randomized trials and 3,308 adults, found that all four exercise types lowered visceral fat, with HIIT ranked first. Both count dose in MET-minutes (intensity in METs times minutes). The first predicted the largest drop at about 750 MET-minutes a week, with a clear effect from about 99 to 1,225, and the second placed the optimum higher, near 1,100, with a significant effect from 430 to 1,420. As arithmetic, 750 MET-minutes means 150 minutes a week at 5 METs; the two optima are model predictions that disagree, not one target.

Diet, weight loss and medicines: what comes off first

Eating less lowered visceral fat too: in the 2023 meta-analysis, caloric restriction reduced it by a moderate effect size of 0.53, pooled from 15 studies. With every method visceral fat shrinks more than subcutaneous fat in percent, yet none targets it; several diets worked without a clear winner, and GLP-1 receptor agonists lowered it in trials.

The two stores behave like a shop's till and its warehouse: when the body draws on its reserves, the small till empties faster relative to what it holds, while more is taken in absolute terms from the large warehouse. That is the pattern a meta-analysis of 89 studies of diet, exercise, drugs and surgery found: in percent the visceral store always shrank more, by every route, while in kilograms the larger subcutaneous store gave up more.

Which diet? Whether the menu matters was tested in a 2026 network meta-analysis of randomized trials in people with overweight or obesity: carbohydrate-restricted eating, intermittent fasting, low-fat diets and plain calorie restriction each lowered visceral fat. Intermittent fasting ranked first (P-score 0.91) and very-low-carbohydrate diets next (0.84), but a ranking is not a size, and the only head-to-head gap the summary reports as significant is very-low- over moderate-carbohydrate diets. The size of the loss matters too: in a review of 61 weight-loss studies, modest losses drew preferentially on visceral fat, an edge that faded with larger losses, and very-low-calorie diets showed an early edge that was gone by 12 to 14 weeks.

Whether medicines lower it as well was tested in a 2026 network meta-analysis of 41 randomized trials with 2,741 patients with overweight or obesity: GLP-1 receptor agonists lowered visceral fat by a large standardized effect size of 0.90 after a mean of 29.4 weeks, and SGLT-2 inhibitors by a moderate one of 0.66. Whether a medicine fits is your doctor's call.

Five and 10 years after two diet-and-exercise trials, 366 participants, mostly men, were examined again: their weight had fully returned, yet visceral fat stayed partly lower, and people who had lost more visceral fat during the trials also had a lower later risk of type 2 diabetes, 28 percent lower for each 10 percent lost (hazard ratio 0.72). That is an association, not proof of cause. For practice, no diet type clearly beat eating less overall, adding exercise lowered visceral fat further in CENTRAL, and a tape, not the scale, shows the change. For lifting itself, see how much fat lifting burns.

More health topics to explore

References

  1. Shuster A et al. — The clinical importance of visceral adiposity: a critical review of methods... (2012)
  2. Abate N et al. — Relationships of generalized and regional adiposity to insulin sensitivity... (1995)
  3. Shen W et al. — Visceral adipose tissue: relations between single-slice areas and total volume (2004)
  4. Fox CS et al. — Abdominal visceral and subcutaneous adipose tissue compartments: association... (2007)
  5. Neeland IJ et al. — Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a... (2019)
  6. Klein S et al. — Absence of an effect of liposuction on insulin action and risk factors for... (2004)
  7. Sahakyan KR et al. — Normal-Weight Central Obesity: Implications for Total and Cardiovascular... (2015)
  8. Jayedi A et al. — Central fatness and risk of all cause mortality: systematic review and... (2020)
  9. NICE — Overweight and obesity management (NG246): identifying and assessing... (2025)
  10. Wang D et al. — Comparison of DXA, BIA, and anthropometry for assessing subcutaneous,... (2026)
  11. Ashwell M et al. — Waist-to-height ratio is a better screening tool than waist circumference... (2012)
  12. Ross R et al. — Waist circumference as a vital sign in clinical practice: a Consensus... (2020)
  13. Ogawa W et al. — Definition, criteria, and core concepts of guidelines for the management of... (2024)
  14. Browning LM et al. — Validity of a new abdominal bioelectrical impedance device to measure... (2010)
  15. Kaul S et al. — Dual-energy X-ray absorptiometry for quantification of visceral fat (2012)
  16. Kuk JL et al. — Age-related changes in total and regional fat distribution (2009)
  17. Lear SA et al. — Elevation in cardiovascular disease risk in South Asians is mediated by... (2012)
  18. Greendale GA et al. — Changes in Regional Fat Distribution and Anthropometric Measures Across the... (2021)
  19. Verheggen RJ et al. — A systematic review and meta-analysis on the effects of exercise training... (2016)
  20. Recchia F et al. — Dose-response effects of exercise and caloric restriction on visceral... (2023)
  21. Vissers D et al. — The effect of exercise on visceral adipose tissue in overweight adults: a... (2013)
  22. Gepner Y et al. — Effect of Distinct Lifestyle Interventions on Mobilization of Fat Storage... (2018)
  23. Deng Y et al. — Optimal Dose and Modality of Exercise for Reducing Visceral Adipose Tissue... (2026)
  24. Ismail I et al. — A systematic review and meta-analysis of the effect of aerobic vs.... (2012)
  25. Xu W et al. — Optimal exercise modality and dose for reducing visceral adipose tissue in... (2026)
  26. Merlotti C et al. — Subcutaneous fat loss is greater than visceral fat loss with diet and... (2017)
  27. Khalafi M et al. — The efficacy of carbohydrate-restricted diets on reducing visceral and liver... (2026)
  28. Chaston TB et al. — Factors associated with percent change in visceral versus subcutaneous... (2008)
  29. Qiao X et al. — Efficacy of Weight-Lowering Agents on Fat Distribution: A Systematic Review... (2026)
  30. Klein H et al. — Lifestyle-Induced Visceral Fat Loss as a Key Target for Durable... (2026)

About this article · Written by the huuman Team. Our content is based on peer-reviewed research and clinical guidelines. We follow editorial standards grounded in scientific evidence.

This article is for educational purposes only and does not constitute medical advice. Health and training decisions should be discussed with qualified professionals.

November 18, 2026
November 20, 2026